Nuevo chat
Historial de búsqueda
Investigación académicaBúsqueda de artículosBibliotecaChats recientes
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
W. White,K. Saag,6 Autores,L. Gunawardhana
2018 · DOI: 10.1056/NEJMoa1710895
New England Journal of Medicine · 697 citas
TLDR
In patients with gout and major cardiovascular coexisting conditions, febuxostat was noninferior to allopurinol with respect to rates of adverse cardiovascular events.